Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Liabilities: 2018-2019

  • Black Diamond Therapeutics' Other Non-Current Liabilities fell 99.60% to $16,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $16,000, marking a year-over-year decrease of 99.60%. This contributed to the annual value of $16,000 for FY2019, which is 99.60% down from last year.
  • Black Diamond Therapeutics' Other Non-Current Liabilities amounted to $16,000 in Q4 2019, which was down 99.60% from $4.0 million recorded in Q4 2018.
  • Over the past 5 years, Black Diamond Therapeutics' Other Non-Current Liabilities peaked at $4.0 million during Q4 2018, and registered a low of $16,000 during Q4 2019.
  • Over the past 2 years, Black Diamond Therapeutics' median Other Non-Current Liabilities value was $2.0 million (recorded in 2018), while the average stood at $2.0 million.
  • Data for Black Diamond Therapeutics' Other Non-Current Liabilities shows a maximum YoY plummeted of 99.60% (in 2019) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' Other Non-Current Liabilities (Quarterly) stood at $4.0 million in 2018, then plummeted by 99.60% to $16,000 in 2019.